Navigation Links
Matthias Spaenle, MD, Joins Oppenheimer's Investment Banking Group as Managing Director - Healthcare
Date:5/18/2011

NEW YORK, May 18, 2011 /PRNewswire/ -- Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings, is pleased to announce that Matthias Spaenle, MD will join the firm as Managing Director in the Healthcare group of the Firm's Investment Bank, where he will help to drive its life science business. He will report to Brian McCarthy, Managing Director and Head of Healthcare Investment Banking.  

Since 2003, Matthias had worked at JMP Securities, where he was a Senior Calling Officer in the Healthcare Group and had focused on biotechnology. Prior to working at JMP, he had worked for Robertson Stephens. A graduate of the Ross School of Business, the University of Michigan, Matthias initially trained in general surgery at the University Hospital Cologne in Cologne, Germany.

"Matthias is an experienced and highly regarded senior banker in the life science space. We are delighted that he's joining our healthcare investment banking team," Mr. McCarthy concluded.

Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), provides a full range of wealth management, securities brokerage and investment banking services to high-net-worth individuals, families, corporate executives, local governments, businesses and institutions.

Certain statements in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, as discussed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Oppenheimer & Co. Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
2. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
3. GM Exec Joins Bio-Reaction Industries Board of Directors
4. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
5. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
6. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
7. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
8. Charles C. Harwood, Jr., Joins Cellectar, Inc.s Board of Directors
9. Chief Technology Officer Joins ACAMP
10. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
11. Food and Beverage Giant Joins Kannapolis Research Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):